The most respected medical journal in the US just eviscerated a drug that's cost taxpayers over $1 billion


A new study published by JAMA Internal Medicine poses a really important question to lawmakers and taxpayers alike. Over the past five years, why has the US government spent $1 billion on a drug that is no more effective than alternatives that are tens of thousands of dollars cheaper per …
Read more on businessinsider.com